Khafagy MM - Search Results

1

Diagnostic value of urinary molecular markers in bladder cancer.

Eissa S, Swellam M, el-Mosallamy H, Mourad MS, Hamdy NΜ, Kamel K, Zaglol AS, Khafagy MM, el-Ahmady O. Eissa S, et al. Among authors: khafagy mm. Anticancer Res. 2003 Sep-Oct;23(5b):4347-55. Anticancer Res. 2003. PMID: 14666650

2

Urinary CA 19.9 as marker for bladder cancer.

Mansour OA, Shouman SA, Khafagy M, Basma H, Liebmann PM, Schauenstein K, el-Ahmady O. Mansour OA, et al. Lancet. 1995 Aug 19;346(8973):512-3. doi: 10.1016/s0140-6736(95)91365-3. Lancet. 1995. PMID: 7637514 No abstract available.

3

Ileocaecal vs ileal neobladder after radical cystectomy in patients with bladder cancer: a comparative study.

Khafagy M, Shaheed FA, Moneim TA. Khafagy M, et al. BJU Int. 2006 Apr;97(4):799-804. doi: 10.1111/j.1464-410X.2006.05996.x. BJU Int. 2006. PMID: 16536777 Clinical Trial.

4

Detection of abnormal lymphocytes in the peripheral blood of COVID-19 cancer patients: diagnostic and prognostic possibility.

Refaat L, Abdellateif MS, Bayoumi A, Khafagy M, Kandeel EZ, Nooh HA. Refaat L, et al. Hematology. 2022 Dec;27(1):745-756. doi: 10.1080/16078454.2022.2089830. Hematology. 2022. PMID: 35724413

5

Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.

Zekri AR, Bahnassy AA, Abdel-Wahab SA, Khafagy MM, Loutfy SA, Radwan H, Shaarawy SM. Zekri AR, et al. Among authors: khafagy mm. J Gastroenterol Hepatol. 2009 Mar;24(3):416-28. doi: 10.1111/j.1440-1746.2008.05699.x. Epub 2008 Nov 27. J Gastroenterol Hepatol. 2009. PMID: 19054267

6

Radical cystectomy and ileocaecal bladder reconstruction for carcinoma of the urinary bladder. A study of 130 patients.

Khafagy MM, el-Kalawy M, Ibrahim A, Safa M, Meguid HA, Bassioni M. Khafagy MM, et al. Br J Urol. 1987 Jul;60(1):60-3. doi: 10.1111/j.1464-410x.1987.tb09135.x. Br J Urol. 1987. PMID: 3620847

7

Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.

Gawad W, Khafagy M, Gamil M, Fakhr I, Negm M, Mokhtar N, Lotayef M, Mansour O. Gawad W, et al. J Egypt Natl Canc Inst. 2014 Sep;26(3):167-73. doi: 10.1016/j.jnci.2014.06.001. Epub 2014 Jun 30. J Egypt Natl Canc Inst. 2014. PMID: 25150132 Free article.

8

Could COVID-19 induce remission of acute leukemia?

Kandeel EZ, Refaat L, Abdel-Fatah R, Samra M, Bayoumi A, Abdellateif MS, Abdel-Hady H, Ali M, Khafagy M. Kandeel EZ, et al. Hematology. 2021 Dec;26(1):870-873. doi: 10.1080/16078454.2021.1992117. Hematology. 2021. PMID: 34719343

9

The role of inflammatory indices in the outcome of COVID-19 cancer patients.

Nooh HA, Abdellateif MS, Refaat L, Kandeel EZ, Bayoumi A, Samra M, Khafagy M. Nooh HA, et al. Med Oncol. 2021 Nov 8;39(1):6. doi: 10.1007/s12032-021-01605-8. Med Oncol. 2021. PMID: 34748094 Free PMC article.

10

The Role of Lymphocyte Subsets, PD-1, and FAS (CD95) in COVID-19 Cancer Patients.

Kandeel EZ, Refaat L, Bayoumi A, Nooh HA, Hammad R, Khafagy M, Abdellateif MS. Kandeel EZ, et al. Viral Immunol. 2022 Sep;35(7):491-502. doi: 10.1089/vim.2022.0036. Epub 2022 Aug 5. Viral Immunol. 2022. PMID: 35930238

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page